Related Experiment Video
Updated: Aug 6, 2026
09:40
Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Geographical variations in TP53 mutational spectrum in ovarian carcinomas
A Dansonka-Mieszkowska1, A H Ludwig, E Kraszewska
1Department of Molecular Pathology, The Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Roentgena 5, 02-781 Warsaw, Poland.
Annals of Human Genetics
|August 16, 2006
Summary
Geographical variations in TP53 gene mutations exist in ovarian cancer. Asian tumors show more exon 7 mutations, while Norwegian tumors exhibit more exon 8 mutations, highlighting regional differences in cancer genetics.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- The TP53 gene is a critical tumor suppressor gene.
- TP53 gene mutations are common in human cancers.
- Mutational spectrum of TP53 varies by tumor type, carcinogen exposure, and molecular context.
Purpose of the Study:
- To compare TP53 gene mutations in ovarian carcinomas across different geographical regions.
- To identify geographical variations in TP53 mutation hotspots and frequencies.
Main Methods:
- Data extraction and verification from the International Agency for Research on Cancer (IARC) database (R10, 2005).
- Analysis of TP53 mutations from 127 ovarian carcinomas.
- Evaluation of 873 TP53 mutations, focusing on exon and amino acid alterations.
Main Results:
- Ovarian tumors from Japan and Korea showed a higher frequency of exon 7 mutations (38%) and lower frequency of exon 8 mutations (11%) compared to Western countries.
- Norwegian tumors had the lowest proportion of exon 7 mutations (19%) and the highest proportion of exon 8 mutations (37%).
- Distinct TP53 mutation hotspots were observed: AA 176 in Poland, AA 220 in the UK, and codon 273 in Norway, with specific amino acid substitutions (HIS vs. CYS) at codon 273 varying by region.
Conclusions:
- Significant geographical variations exist in the TP53 gene mutational spectrum of ovarian carcinomas.
- These regional differences in TP53 mutations may be influenced by genetic background or environmental factors.
- Further geographical analysis of TP53 gene mutations in ovarian cancer is warranted to gain deeper insights.
